DESCRIPTION:
id: 0d904a70-4bef-4344-97f0-77e5988269ba
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
Sodium Chloride Injection, USP, 0.9% is a sterile, nonpyrogenic solution. The osmolarity is 300 mOsmol per liter (calculated).
Each mL contains: Sodium chloride 9 mg; Water for Injection q.s. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single dose containers. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (pH 4.5-7.0).
Sodium chloride occurs as colorless cubic crystals or white crystalline powder and has a saline taste. Sodium chloride is freely soluble in water. It is soluble in glycerin and slightly soluble in alcohol.
The empirical formula for sodium chloride is NaCl and the molecular weight is 58.44.
CLINICAL PHARMACOLOGY:
id: 4f98bfc5-c48d-40a7-948f-d3011a7fd7b8
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl—) ions. These ions are normal constituents of the body fluids (principally extracellular) and are essential for maintaining electrolyte balance.
The distribution and excretion of sodium (Na+) and chloride (Cl—) are largely under the control of the kidney which maintains a balance between intake and output.
The small volume of fluid and amount of sodium chloride provided by Sodium Chloride Injection, USP, 0.9%, when used only as a vehicle for parenteral injection of drugs, is unlikely to exert a significant effect on fluid and electrolyte balance except possibly in very small infants.
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1 to 1.5 liters each for insensible water loss by perspiration and urine production).
Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.
INDICATIONS AND USAGE:
id: cabf15cb-781b-4e0d-b3a9-f6e9ed4c4a1c
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
Sodium Chloride Injection, USP, 0.9% preparations are indicated for diluting or dissolving drugs for intramuscular, intravenous or subcutaneous injection according to instructions of the manufacturer of the drug to be administered.
Sodium Chloride Injection, USP, 0.9% is also indicated for use in flushing of intravenous catheters.
WARNINGS:
id: e2fcea0e-872e-4b37-8b0f-24341f1f87a1
displayName: WARNINGS SECTION
FDA Article Code: 34071-1
For use in newborns, when a sodium chloride solution is required for preparation or diluting medications or in flushing intravenous catheters, only preservative free Sodium Chloride Injection, USP, 0.9% should be used.
ADVERSE REACTIONS:
id: 28b00e45-e69f-4247-a7c0-16ba5caf7a93
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures and, if possible, retrieve and save the remainder of the unused vehicle for examination.
OVERDOSAGE:
id: 1e2ed7a7-d78b-4e97-bec6-971a8faebd39
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
When used as a diluent, solvent or intravascular flushing solution, this parenteral preparation is unlikely to pose a threat of sodium chloride or fluid overload except possibly in very small infants. In the event these should occur, reevaluate the patient and institute appropriate corrective measures. (See
PRECAUTIONS and
ADVERSE REACTIONS
).
DOSAGE AND ADMINISTRATION:
id: 67eff1b3-b457-4df8-a0aa-dc5f6186b504
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
Before Sodium Chloride Injection, USP, 0.9% is used as a vehicle for the administration of a drug, specific references should be checked for any possible incompatibility with sodium chloride.
The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.
Sodium Chloride Injection, USP, 0.9% is also indicated for use in flushing intravenous catheters. Prior to and after administration of the medication, the intravenous catheter should be flushed in its entirety with Sodium Chloride Injection, USP, 0.9%. Use in accord with any warnings or precautions appropriate to the medication being administered.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
HOW SUPPLIED:
id: c1ee8188-c32e-4a33-9077-2997bacde855
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
Product: 50090-2488
NDC: 50090-2488-0 10 mL in a VIAL, SINGLE-DOSE
SODIUM CHLORIDE
id: d315fe16-cc3e-4b9c-815f-6992fcd02f9e
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
